Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration]
iQoncept/iStock via Getty Images

As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary laggards, with the Health Care Select Sector SPDR Fund (XLV [https://seekingalpha.com/symbol/XLV]) down 5.29% in Q1 2026, slightly underperforming the S&P 500's 4.63% decline amid inflation pressures, rising Treasury yields, and tighter Medicare Advantage reimbursement conditions.

Against that challenging backdrop, upward EPS revisions within the small-cap healthcare space stand out as a particularly meaningful signal, indicating that analysts see company-specific catalysts strong enough to override sector-wide headwinds.

The following list highlights small-cap healthcare stocks that have earned the highest possible Seeking Alpha EPS Revision Grade of A+, spanning biotechnology, pharmaceuticals, health care services, and health care equipment.

The list includes Design Therapeutics, Inc. (DSGN [https://seekingalpha.com/symbol/DSGN]), Immuneering Corporation (IMRX [https://seekingalpha.com/symbol/IMRX]), and InnovAge Holding Corp. (INNV [https://seekingalpha.com/symbol/INNV]), all carrying the highest A+ EPS revision grade. InnovAge Holding Corp. (INNV [https://seekingalpha.com/symbol/INNV]) stands out with a Strong Buy quant rating of 4.87, while KalVista Pharmaceuticals, Inc. (KALV [https://seekingalpha.com/symbol/KALV]) follows closely with a Strong Buy rating of 4.66.

The list features diversity across healthcare subsectors, including biotechnology firms like Kyverna Therapeutics, Inc. (KYTX [https://seekingalpha.com/symbol/KYTX]) and vTv Therapeutics Inc. (VTVT [https://seekingalpha.com/symbol/VTVT]), as well as health care equipment providers such as Pulse Biosciences, Inc. (PLSE [https://seekingalpha.com/symbol/PLSE]) and Tactile Systems Technology, Inc. (TCMD [https://seekingalpha.com/symbol/TCMD]). Theravance Biopharma, Inc. (TBPH [https://seekingalpha.com/symbol/TBPH]) represents the pharmaceuticals industry with a Strong Buy rating of 4.56.

Here is the list:

*
Design Therapeutics, Inc. (DSGN [https://seekingalpha.com/symbol/DSGN]), EPS Revision: A+

*
Immuneering Corporation (IMRX [https://seekingalpha.com/symbol/IMRX]), EPS Revision: A+

*
InnovAge Holding Corp. (INNV [https://seekingalpha.com/symbol/INNV]), EPS Revision: A+

*
KalVista Pharmaceuticals, Inc. (KALV [https://seekingalpha.com/symbol/KALV]), EPS Revision: A+

*
Kyverna Therapeutics, Inc. (KYTX [https://seekingalpha.com/symbol/KYTX]), EPS Revision: A+

*
Precigen, Inc. (PGEN [https://seekingalpha.com/symbol/PGEN]), EPS Revision: A+

*
Pulse Biosciences, Inc. (PLSE [https://seekingalpha.com/symbol/PLSE]), EPS Revision: A+

*
Theravance Biopharma, Inc. (TBPH [https://seekingalpha.com/symbol/TBPH]), EPS Revision: A+

*
Tactile Systems Technology, Inc. (TCMD [https://seekingalpha.com/symbol/TCMD]), EPS Revision: A+

*
vTv Therapeutics Inc. (VTVT [https://seekingalpha.com/symbol/VTVT]), EPS Revision: A+

*
GeneDx Holdings Corp. (WGS [https://seekingalpha.com/symbol/WGS]), EPS Revision: A+

*
X4 Pharmaceuticals, Inc. (XFOR [https://seekingalpha.com/symbol/XFOR]), EPS Revision: A+

Health Care ETFs: (XLV [https://seekingalpha.com/symbol/XLV]), (VHT [https://seekingalpha.com/symbol/VHT]), (IHI [https://seekingalpha.com/symbol/IHI]), (IXJ [https://seekingalpha.com/symbol/IXJ]), (IYH [https://seekingalpha.com/symbol/IYH]), (FHLC [https://seekingalpha.com/symbol/FHLC]), and (FXH [https://seekingalpha.com/symbol/FXH])

MORE ON HEALTHCARE STOCKS

* IHI: Pullback Creates A Buying Opportunity In High-Growth MedTech [https://seekingalpha.com/article/4884878-ihi-etf-pullback-creates-buying-opportunity-high-growth-medtech]
* Routine Vaccines Okay For Now: Investment Implications Of The Court Decision [https://seekingalpha.com/article/4883587-routine-vaccines-okay-for-now-investment-implications-of-the-court-decision]
* Sector Rotation: Healthcare XLV Should Be The Next Stop [https://seekingalpha.com/article/4875728-sector-rotation-healthcare-xlv-should-be-the-next-stop]
* Centessa is the top performing foreign healthcare stock YTD [https://seekingalpha.com/news/4573565-centessa-is-the-top-performing-foreign-healthcare-stock-ytd]
* Weekly ETF flows: Five of 11 sectors record outflows; energy sector leads inflows [https://seekingalpha.com/news/4573068-weekly-etf-flows-five-of-11-sectors-record-outflows-energy-sector-leads-inflows]